Investors push biotech Imugene to 13-year price high
SYDNEY: Shares in $620 million biotech Imugene today hit their highest since January 2008 after
SYDNEY: Shares in $620 million biotech Imugene today hit their highest since January 2008 after
FEATURED
Property group reveals revised mixed-use housing development plans
Best retirement housing design for Global Awards shortlisted
Vision for affordable and sustainable multigenerational housing canvassed by experts
Intergenerational social housing boom in particular now underway
Study pinpoints mealtime issues in nursing home residents with dementia
Nursing home ownership moves represent major risk to future survival of sector
INNOVATION
